Mar. 31 at 8:48 PM
$LEGN
The stupidity of Analyst ratings in a nutshell😂:
With a "Moderate Buy" rating and price target of
$58.31 Truist Financial downgraded LEGN from a "strong-buy" to a "hold".
A number of other research firms also recently weighed in on LEGN:
Morgan Stanley decreased their price target from
$50.00 to
$49.00 and set an "overweight" rating for the company in a report on March 11th.
Rothschild downgraded Legend Biotech from a "buy" rating to a "neutral" rating and set a
$24.00 target price.
Oppenheimer issued an "outperform" rating and a
$75.00 price target on the stock.
UBS Group decreased their price target from
$54.00 to
$48.00 and set a "buy" rating.
Finally Weiss restated a "sell" rating 🤔🤣
11 analysts have rated the stock with a Buy rating, 3 have assigned a Hold rating and 1 has given a Sell rating.
With a current price of app.
$18 the stock has a consensus rating of "Moderate Buy" and an average price target of
$58.31
😄😁😁😁🤔😂
